Affordable Access

Publisher Website

Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency

Authors
Journal
Cytokine
1043-4666
Publisher
Elsevier
Volume
65
Issue
1
Identifiers
DOI: 10.1016/j.cyto.2013.09.007
Keywords
  • X-Linked Inhibitor Of Apoptosis (Xiap)
  • X-Linked Lymphoproliferative Syndrome (Xlp)
  • Interleukin-18
  • Hemophagocytic Lymphohistiocytosis (Hlh)

Abstract

Abstract X-linked lymphoproliferative syndrome (XLP) is a rare primary immunodeficiency characterized by increased vulnerability to Epstein–Barr virus infection. XLP type 1 is caused by mutations in SH2D1A, whereas X-linked inhibitor of apoptosis (XIAP) encoded by XIAP/BIRC4 is mutated in XLP type 2. In XIAP deficiency, hemophagocytic lymphohistiocytosis (HLH) occurs more frequently and recurrence is common. However, the underlying mechanisms remain mostly unknown. We describe the characteristics of the cytokine profiles of serum samples from 10 XIAP-deficient patients. The concentration of interleukin (IL)-18 was strikingly elevated in the patients presented with HLH, and remained high after the recovery from HLH although levels of other pro-inflammatory cytokines approached the normal range. Longitudinal examination of two patients demonstrated marked exacerbation of IL-18 levels during every occasion of HLH. These findings may suggest the association between HLH susceptibility and high serum IL-18 levels in XIAP deficiency.

There are no comments yet on this publication. Be the first to share your thoughts.